Implementing Vancomycin Reducing Practices (VRP) in Preterm Infants

Status: Recruiting
Location: See all (13) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Level III NICU

• Affiliated with Kaiser Permanente Northern California (KPNC) or Children's Hospital of Philadelphia Newborn Care Network (CNBCN)

• Recruited by study team

Locations
United States
California
Kaiser Permanente Modesto Medical Center
RECRUITING
Modesto
Kaiser Permanente East Bay - Oakland Medical Center
RECRUITING
Oakland
Kaiser Permanente Roseville Medical Center
RECRUITING
Roseville
Kaiser Permanente San Francisco Medical Center
RECRUITING
San Francisco
Kaiser Permanente San Leandro Medical Center
RECRUITING
San Leandro
Kaiser Permanente Santa Clara Medical Center
RECRUITING
Santa Clara
Kaiser Permanente Walnut Creek Medical Center
RECRUITING
Walnut Creek
New Jersey
Medical Center of Princeton
RECRUITING
Plainsboro
Virtua Voorhees
RECRUITING
Voorhees Township
Pennsylvania
Lancaster General Hospital
RECRUITING
Lancaster
Hospital of the University of Pennsylvania
RECRUITING
Philadelphia
Pennsylvania Hospital
RECRUITING
Philadelphia
Chester County Hospital
RECRUITING
West Chester
Contact Information
Primary
Kayla Gilpin
kayla.gilpin@pennmedicine.upenn.edu
215-573-3976
Backup
Hanna Rosewood
rosewoodh@chop.edu
267-271-8300
Time Frame
Start Date: 2025-06-02
Estimated Completion Date: 2027-09
Participants
Target number of participants: 13
Treatments
Experimental: Sites receiving external facilitation
Sites will receive guidance from an external facilitator to support uptake of the VRP.
No_intervention: Sites not receiving external facilitation
Sites will not receive guidance from an external facilitator.
Related Therapeutic Areas
Sponsors
Leads: Children's Hospital of Philadelphia
Collaborators: Agency for Healthcare Research and Quality (AHRQ)

This content was sourced from clinicaltrials.gov